HH
FPRX

Hilltop Holdings’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Hilltop Holdings’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-33,337
Closed -$447K – 423
2019
Q1 		$447K Sell
33,337
-2,809
-8% -$32K 0.09% 216
2018
Q4 		$336K Sell
36,146
-3,678
-9% -$43.8K 0.08% 231
2018
Q3 		$554K Sell
39,824
-25,651
-39% -$381K 0.12% 215
2018
Q2 		$1.03M Buy
65,475
+13,500
+26% +$236K 0.22% 115
2018
Q1 		$893K Buy
+51,975
New +$1.01M 0.16% 158

Other funds holding FPRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hilltop Holdings's FPRX Position: Q2 2019 in Review

Hilltop Holdings sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2019, closing a stake of 33,337 shares — an estimated $447K sold.

Hilltop Holdings first reported a position in FPRX in Q1 2018 and held it in 5 quarters. The position peaked at $1.03M in Q2 2018. 114 funds tracked by Wall St. Rank hold FPRX as of Q2 2019.

  • Hilltop Holdings reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Hilltop Holdings sold 33,337 Five Prime Therapeutics, Inc. shares in Q2 2019, an estimated $447K.
  • Hilltop Holdings first reported a position in Five Prime Therapeutics, Inc. in Q1 2018 and held it in 5 quarters.
  • Hilltop Holdings's Five Prime Therapeutics, Inc. position peaked at $1.03M in Q2 2018.
  • 114 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2019.

Based on Hilltop Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.